Comment on "Cost Effectiveness of Vericiguat for the Treatment of Chronic Heart Failure with Reduced Ejection Fraction Following a Worsening Heart Failure Event from a US Medicare Perspective".
- Published in:
- 2022
- By:
- Publication type:
- Letter
Works matching IS 11707690 AND DT 2022 AND VI 40 AND IP 9
Results: 7
1
2
The Cost Effectiveness of Axicabtagene Ciloleucel Versus Best Supportive Care in the Treatment of Adult Patients with Relapsed or Refractory Large B-Cell Lymphoma (LBCL) After Two or More Lines of Systemic Therapy in Canada.
- Published in:
- 2022
- By:
- Publication type:
- journal article
3
Belimumab for Treating Active Autoantibody-Positive Systemic Lupus Erythematosus: An Evidence Review Group Perspective of a NICE Single Technology Appraisal.
- Published in:
- 2022
- By:
- Publication type:
- journal article
4
Carers' Health-Related Quality of Life in Global Health Technology Assessment: Guidance, Case Studies and Recommendations.
- Published in:
- 2022
- By:
- Publication type:
- journal article
5
Best-Worst Scaling and the Prioritization of Objects in Health: A Systematic Review.
- Published in:
- 2022
- By:
- Publication type:
- research
6
Does the Structure Matter? An External Validation and Health Economic Results Comparison of Event Simulation Approaches in Severe Obesity.
- Published in:
- 2022
- By:
- Publication type:
- journal article
7
A Systematic Review of the Methodologies and Modelling Approaches Used to Generate International EQ-5D-5L Value Sets.
- Published in:
- 2022
- By:
- Publication type:
- research